Craft

AliveDx

Total Funding

$43.2 M

Revenue

$38.5 M

FY, 2022

AliveDx Summary

Company Summary

Overview
AliveDx Suisse (formerly known as Quotient Suisse) is a company that develops and manufactures transfusion diagnostics products. It offers Alba, a blood bank reagents portfolio; MosaiQ, a multiplexing and multimodality automated testing platform; LumiQ, a system for screening and identification of autoimmune diseases; and other solutions.
Type
Private
Status
Active
Founded
2007
HQ
Eysins, CH | view all locations
Website
https://alivedx.com/
Cybersecurity rating
ESG rating
40-49 out of 100|View all ESG data
Sectors

Key People

  • Frederick Hallsworth, Director

    • Brian McDonough, Director

      • Ed Farrell

        Ed Farrell, Chief Operating Officer

      • Isabelle Buckle, Director

        LocationsView all

        4 locations detected

        • Eysins, VD HQ

          Switzerland

          Route de Crassier 13

        • Chicago, IL

          United States

          171 N Aberdeen St Suite 400

        • Dubai, Dubai

          United Arab Emirates

          Building 26 Office 211 (Level 2) Dubai Healthcare City

        • Milton Bridge

          United Kingdom

          5 James Hamilton Way

        AliveDx Financials

        Summary Financials

        Revenue (Q3, 2023)
        $10.0M
        Gross profit (Q3, 2023)
        $7.4M
        Net income (Q3, 2023)
        ($13.3M)
        Cash (Q3, 2023)
        $11.9M
        EBIT (Q3, 2023)
        $6.8M

        Footer menu